Inflation Finally Eases

A Bit of Inflation Relief in July | How to Beef Up Your Portfolio Against Inflation | IRA Bill a Blessing in Disguise for Drug Stocks? Created for {EMAIL} | [Web Version]( August 10, 2022 CONNECT WITH KIPLINGER  [LinkedIn]( [Facebook]( [Twitter]( [Instagram ]( [Youtube]( [SIGN UP]( ⋅ [WEBSITE]( [] Inflation [] [A Bit of Inflation Relief in July]( Consumer prices were unchanged, on average, in July because of a large drop in gasoline prices and a smaller decline in natural gas from the previous month. While [lower prices at the gas pump]( are a welcome respite for drivers, prices still rose strongly for basics like food, rent and new vehicles. The annual inflation rate edged down to 8.5% from 9.1% in June. [READ MORE]( [Hear How Banking Ecosystems Offer Accelerated Growth]( Join this webinar to listen to Financial Services experts discuss trends and success stories. [READ MORE]( ADVERTISEMENT [] More Inflation [] [How to Beef Up Your Portfolio Against Inflation]( “The deceleration in the consumer price index for July is likely a big relief for the Federal Reserve,” says Nancy Davis, portfolio manager of the Quadratic Interest Rate Volatility and Inflation Hedge ETF ([IVOL](). “If we continue to see declining inflation prints, the Federal Reserve may start to slow the pace of monetary tightening.” Still, with consumer prices running hot, investors should continue to protect their portfolios against inflation. [READ MORE]( [These Are the Top Financial Advisors in the US]( Hiring the wrong financial advisor can wreak havoc on your retirement and can potentially cost a big chunk of your savings. [READ MORE]( ADVERTISEMENT [] Health Care Investing [] [IRA Bill a Blessing in Disguise for Drug Stocks?]( At first glance, the measures to curb drug price increases in the [Inflation Reduction Act]( seem like negatives for pharma and biotech stocks. If passed, as expected, Medicare would be allowed to negotiate the price it pays for a limited number of drugs. Beginning in 2026, up to 10 of Medicare’s highest-cost drugs would be included in negotiations, rising to the top 20 by 2029. In 2025, an annual $2,000 cap would be introduced on Medicare beneficiaries’ out-of-pocket prescription drug costs. But strategists at UBS Securities see some silver linings. [READ MORE]( [] Also on Kiplinger [] Free download, [The Kiplinger Letter's Forecast](. No information required from you. - [Amazon Layaway: A New Perk of Amazon Prime]( - [Buffett Goes on Buying Spree as Stock Market Reels]( - [Inflation Reduction Act Would Boost Obamacare Tax Credit]( - [The Inflation Reduction Act and Taxes: What You Should Know]( - [Sign Up for Kiplinger's Free Tax Tips E-Newsletter for Money-Saving Tax Planning and Compliance Advice]( ABOUT KIPLINGER When we write about money, we get it right. So the decisions you make with your dollars are also right. Since 1920, Kiplinger has earned a reputation as a trusted provider of unbiased financial advice, objective business and economic forecasts, and practical help to millions of business professionals, investors, and individuals seeking to make more profitable decisions with their money. Our [flagship publications]( include Kiplinger’s Personal Finance magazine, The Kiplinger Letter, The Kiplinger Tax Letter, Kiplinger’s Retirement Report, and Kiplinger’s Investing for Income. All are regarded as the leading publications in their respective fields. Every day, millions of readers rely on our [free e-newsletters]( and [podcasts]( for help on everything from getting the best rate on a mortgage or car loan, to managing their businesses in an uncertain world, avoiding an IRS audit, building wealth for a secure retirement, or investing wisely in any kind of market. Now it’s your turn to reap all the rewards Kiplinger has to offer. Visit [Kiplinger.com](, your gateway to all of the above and much more. Check in any time for our latest advice on how to make more money, and keep more of the money you make. Stay right on the money, with Kiplinger. [Sign Up]( | [Print Publications]( | [Unsubscribe]( [Privacy Policy]( | [Cookies Policy]( | [Terms and Conditions]( CONTACT US: [FEEDBACK](concat('mailto:',$brief_feedback_email)) | [ADVERTISE]( Future US LLC © 1100 13th St. NW, Suite 1000, Washington, DC 20005